Clinical trial
Therapeutic Interactive Voice Response (IVR) for Relapse Prevention in Chronic Pain
NCT00266773 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Interactive Voice Response (IVR) for Relapse Prevention in Chronic Pain
- Lead sponsor
- University of Vermont
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- January 31, 2012
- Enrollment
- 158 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain and relapse prevention